Product Information

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET is a generic product labeled by Aurolife Pharma LLC, priced at $0.2341 per EA under NDC 13107021201. Its NADAC has been published 373 times since Oct 2, 2019.

FDA first approved this application on Sep 13, 2018. Its Orange Book therapeutic-equivalence code is AA.

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET

Hydrocodone Bitartrate and Acetaminophen
$0.2341per EA
DEA Schedule CII

Strength

300; 7.5 mg/1; mg/1

NDC

13107021201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA207709

FDA Approved

9/13/2018

TE Code

AA

On Market Since

5/6/2015

Pharmacological Classes

Opioid Agonist
Opioid Agonists

Price Statistics

The NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has been published 373 times since Oct 2, 2019, and over the history we have for it it has declined 41.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2341 per EA
All-time high$0.6564 (Jun 10, 2020)
All-time low$0.1542 (Jul 17, 2024)
52-week high$0.2412
52-week low$0.1719
Median price$0.2433
Average price$0.2915
Largest weekly change+89.2% (Apr 22, 2020)
Weeks tracked373
Tracking sinceOct 2, 2019

Price History

1W

-3.0%

1M

+9.5%

3M

+19.9%

6M

+22.5%

1Y

+22.4%

3Y

-46.9%

5Y

-25.5%

All

-41.9%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, manufactured by Aurolife Pharma LLC, is $0.2341 per EA (NDC 13107021201), effective Nov 18, 2026.

How has the price of HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has declined 41.9%. It has been tracked across 373 weekly CMS publications since Oct 2, 2019.

What are the highest and lowest recorded NADAC prices for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

Since Oct 2, 2019, the NADAC for HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET has ranged from a low of $0.1542 (Jul 17, 2024) to a high of $0.6564 (Jun 10, 2020), with a median of $0.2433 per EA.

Are there cheaper alternatives to HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET, is $0.1741 per EA — about 26% below HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET.

Who manufactures HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET?

HYDROCODONE-ACETAMINOPHEN 7.5-300 MG TABLET (NDC 13107021201) is labeled by Aurolife Pharma LLC, and CMS classifies it as a generic product.